The P-Shot is an injection of platelet-rich plasma, concentrated from your own blood, into the penis. It is aimed at erectile function rather than size. Randomized trials show modest improvement in erectile scores at 12 and 24 weeks, though the evidence base remains inconsistent.
The P-Shot is a branded name for an injection of platelet-rich plasma into the penis. A small volume of your blood is drawn, spun in a centrifuge to concentrate the platelets, and that concentrate is injected into the erectile bodies.
Platelets carry growth factors that coordinate tissue repair — PDGF, TGF-beta, VEGF and others. The rationale is that concentrating them may improve blood flow and tissue quality in the penis. Because the material is your own blood, allergic reaction and rejection are not concerns.
The P-Shot is not a size treatment. It is aimed at erectile function. It does not add girth, and it does not add length.
If your goal is girth, the relevant procedure is penile filler — a completely different treatment. Any clinic marketing the P-Shot primarily as an enlargement procedure is misrepresenting it.
This is a field where marketing has run well ahead of data, so here is where the research actually stands.
A 2025 systematic review and meta-analysis pooled seven randomized controlled trials covering 660 patients. It found that compared with control, men receiving PRP showed statistically significant improvement in IIEF scores — the standard erectile function questionnaire — at 12 weeks and 24 weeks. Notably, there was no significant difference at 4 weeks.
A separate 2024 systematic review of four studies covering 413 patients was more cautious, concluding there is still no conclusive evidence regarding efficacy.
Reviewers consistently flag the same problem: enormous variability in how PRP is prepared, in dosage, and in follow-up protocols. Two clinics offering "the P-Shot" may be injecting materially different products. That variability makes results hard to compare and is a large part of why the evidence looks inconsistent.
The fair summary: small to moderate benefit for erectile function in some men, emerging but not settled, with a good safety profile.
PRP uses your own blood, which removes the risk of allergy or rejection. Across the studies, side effects were described as mild and transient, with no major adverse events reported. Typical issues are discomfort during injection, bruising, and temporary swelling.
It is avoided with platelet disorders, active infection, certain cancers, and anticoagulation that cannot be paused.
Who it does not suit: anyone seeking size, and anyone who has not had erectile dysfunction properly evaluated first.
This matters more than the injection. Erectile dysfunction is frequently an early marker of cardiovascular disease — the arteries supplying the penis are considerably narrower than the coronary arteries, so atherosclerosis often produces erectile symptoms years before cardiac symptoms.
A clinic that injects PRP without assessing blood pressure, lipids, blood sugar and testosterone is treating a symptom and ignoring a warning. An erectile dysfunction evaluation should come before any procedure.
Continue to whether the P-Shot is worth it, or compare it against penile filler.
Reviewed by Daniel Moghadam, M.D.
Founder and medical director of Modern Aesthetica in Beverly Hills. Dr. Moghadam performs all injectable procedures personally. This article is educational and is not a substitute for a consultation — what is appropriate for you depends on examination.
An injection of platelet-rich plasma — concentrated from your own blood — into the penis. It targets erectile function rather than size, using growth factors from your platelets to support blood flow and tissue quality.
No. The P-Shot is aimed at erectile function, not girth or length. If size is your goal, penile filler is the relevant procedure. Any clinic marketing the P-Shot as an enlargement treatment is misrepresenting what it does.
The evidence is emerging rather than settled. A 2025 meta-analysis of seven randomized trials (660 patients) found significant improvement in erectile function scores at 12 and 24 weeks versus control, though a 2024 review of four studies found no conclusive evidence. Benefits appear small to moderate.
It has a good safety profile. Because it uses your own blood there is no risk of allergy or rejection, and studies report mild, transient side effects with no major adverse events. It is avoided with platelet disorders, active infection, or anticoagulation that cannot be paused.
Not immediately. The pooled trial data found no significant difference from control at 4 weeks, with benefit appearing at 12 and 24 weeks. It stimulates a biological process rather than producing an instant effect.
Yes, and this matters more than the injection. Erectile dysfunction is frequently an early marker of cardiovascular disease, since penile arteries are narrower than coronary arteries. Any provider injecting without assessing blood pressure, lipids, blood sugar and testosterone is ignoring a warning sign.
An erectile dysfunction evaluation identifies what is actually causing the problem — which sometimes matters far more than the treatment.